These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18205876)

  • 21. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
    Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
    Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
    Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
    Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Child-onset systemic sclerosis positive for anticentromere antibodies: two Japanese cases.
    Inamo Y
    Pediatr Int; 2012 Dec; 54(6):941-4. PubMed ID: 23279029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinuclear antibody in systemic sclerosis (scleroderma).
    Okano Y
    Rheum Dis Clin North Am; 1996 Nov; 22(4):709-35. PubMed ID: 8923592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-U3 RNP autoantibodies in systemic sclerosis.
    Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
    Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
    Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
    Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
    Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis.
    Igarashi A; Takehara K; Soma Y; Kikuchi K; Ishibashi Y
    Dermatologica; 1990; 180(3):136-40. PubMed ID: 2340922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis.
    Clark KEN; Campochiaro C; Csomor E; Taylor A; Nevin K; Galwey N; Morse MA; Singh J; Teo YV; Ong VH; Derrett-Smith E; Wisniacki N; Flint SM; Denton CP
    Ann Rheum Dis; 2021 Dec; 80(12):1584-1593. PubMed ID: 34230031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Scleroderma--systemic sclerosis. Serology, lung function and survival].
    Ullman S; Halberg P; Wiik A; Jacobsen S
    Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
    Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical relevance of autoantibodies in scleroderma.
    Ho KT; Reveille JD
    Arthritis Res Ther; 2003; 5(2):80-93. PubMed ID: 12718748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
    Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
    J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
    Aoyama K; Nagai Y; Endo Y; Ishikawa O
    J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.
    Kuwana M; Inoko H; Kameda H; Nojima T; Sato S; Nakamura K; Ogasawara T; Hirakata M; Ohosone Y; Kaburaki J; Okano Y; Mimori T
    Intern Med; 1999 Apr; 38(4):336-44. PubMed ID: 10361906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.